| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Immunology and Cell Biology,
Department of Pediatrics, Graduate School of Medicine, and
Research Institute for Food Science, Kyoto University, Kyoto, Japan;
§
The Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan; and
¶
Asahi Breweries, Tokyo, Japan
Hyposensitization therapy for atopic diseases has been conducted for decades but suffered from many problems including anaphylactic reactions. We previously developed a mutant protein of the major mite allergen Derf-2, C8/119S, which showed reduced binding to IgE. The C8/119S mutant was shown to exhibit more efficient hyposensitizing effect than Derf-2 in the animal model of allergic bronchial asthma. In the present study, we indicate that C8/119S exhibits markedly augmented immunogenicity for the proliferation of Derf-2-specific human T cells and T cell clones irrespective of the epitope specificity as compared with Derf-2. Furthermore, C8/119S has induced potent and almost exclusive differentiation of Th1 cells from the peripheral blood of atopic patients in vitro. Neither Ag dosage effect nor absence of B cell-mediated Ag presentation could fully account for these effects. C8/119S has been indicated to lose the characteristic ß-barrel structure as judged by circular dichroism spectroscopic analysis and to polymerize solubly in physiological condition. Heating of Derf-2 also caused less stable molecular aggregation, but it hardly affected the secondary structure and failed to induce such a polarity toward the Th1 cell differentiation. These results have indicated that the degenerate secondary structure of C8/119S leading to stable molecular polymerization is primarily responsible for the marked increase in T cell-immunogenicity and the induction of exclusive Th1 cell differentiation in atopic patients. It has been suggested strongly that the recombinant C8/119S protein can provide an effective Ag with the least risk of anaphylaxis for allergen immunotherapy against house dust mite in human.
This article has been cited by other articles:
|
|
 |
|
  D. E. Kean, H. S. Goodridge, S. McGuinness, M. M. Harnett, M. J. C. Alcocer, and W. Harnett Differential Polarization of Immune Responses by Plant 2S Seed Albumins, Ber e 1, and SFA8 J. Immunol., August 1, 2006; 177(3): 1561 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kikuchi, T. Takai, T. Kuhara, M. Ota, T. Kato, H. Hatanaka, S. Ichikawa, T. Tokura, H. Akiba, K. Mitsuishi, et al. Crucial Commitment of Proteolytic Activity of a Purified Recombinant Major House Dust Mite Allergen Der p1 to Sensitization toward IgE and IgG Responses J. Immunol., August 1, 2006; 177(3): 1609 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Berguer, J. Mundinano, I. Piazzon, and F. A. Goldbaum A Polymeric Bacterial Protein Activates Dendritic Cells via TLR4 J. Immunol., February 15, 2006; 176(4): 2366 - 2372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Drew, N. P. Eusebius, L. Kenins, H. D. de Silva, C. Suphioglu, J. M. Rolland, and R. E. O'Hehir Hypoallergenic Variants of the Major Latex Allergen Hev b 6.01 Retaining Human T Lymphocyte Reactivity J. Immunol., November 1, 2004; 173(9): 5872 - 5879. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
